horse breath
Boehringer Ingelheim Animal Health recently announced the recipients of the 2022 Advancement in Equine Research Awards during the 68th annual American Association of Equine Practitioners Convention, held in San Antonio, Texas, Nov. 18-22. The recipients were chosen based on their research proposals centered on equine infectious respiratory disease and equine asthma syndrome.

Recipients include the following:

Renaud Leguillette, DVM, MSs, PhD, DACVIM, ACVSMR, and Macarena Sanz, DVM, PhD, DACVIM
University of Calgary College of Veterinary Medicine, AB, Canada

Shadira Gordon, DVM, MPVM, and Nicola Pusterla, DVM, PhD, DACVIM, DAVDC
University of California, Davis

Noah D. Cohan, VMD, MPH, PhD
Texas AgriLife Research—College of Veterinary Medicine, College Station

Shannon Massie, MS, and Renaud Leguillette, DVM, MSc, PhD, DACVIM, ACVSMR
University of Calgary College of Veterinary Medicine, Calgary, AB, Canada

Shadira Gordon, DVM, MPVM, Nicola Pusterla, DVM, PhD, DACVIM, DAVDC, and Beatriz Martinez Lopez, DVM, MPVM, PhD
University of California, Davis

Each recipient will receive $15,000 in support of their research. With the inclusion of this year’s recipients, Boehringer Ingelheim has given more than $700,000 towards the advancement of equine research since 2011.

“At Boehringer Ingelheim, we acknowledge that the health and well-being of animals is pivotal to the success and development of human life. Our dedication and passion for the advancement of equine research makes Boehringer Ingelheim a global leader in its field,” said Steve Grubbs, DVM, PhD, DACVIM, equine technical manager for BI. “Previous award recipients have made novel research advancements in equine infectious and noninfectious respiratory diseases, and we anticipate that this year’s grantees will follow suit.”

Those eligible to submit proposals were veterinarians, diagnosticians, and public and private researchers in the United States, Canada, and Mexico.

For more information about the Advancement in Equine Research Awards, click here.